Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study
about
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.Antimalarial activity of Garcinia mangostana L rind and its synergistic effect with artemisinin in vitro.A bibliometric analysis of literature on malaria vector resistance: (1996 - 2015).Emerging polymorphisms in falciparum Kelch 13 gene in Northeastern region of India.Therapeutic efficacy and artemisinin resistance in northern Myanmar: evidence from in vivo and molecular marker studies.Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveller coming from Ethiopia.Plasmodium falciparum Kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin State, Myanmar.Role of K13 Mutations in Artemisinin-Based Combination Therapy.Efficacy of Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Cruzeiro do Sul, Brazil, 2016.Aptamer Technology: Adjunct Therapy for Malaria.Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar.Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis
P2860
Q33655603-2BC67ED5-56C3-459A-A3B2-8E1AED557729Q36292086-7D1BA538-88D1-4B1E-9E6C-F82DB19C0601Q37440464-5C3E2DB7-DEC1-4D59-B7E2-E0411157D639Q37470416-8CD4C246-8A01-4AE4-A774-6D166E1B6EF6Q37740974-FE3A0FEA-FA40-45A3-9C16-27340A87381BQ39025693-2919568C-D591-4492-A5A1-A79F8C2E4D9BQ47142321-3CD90BEA-DC9D-440F-8D9A-E86BF0BA83C1Q47973052-4785DCAF-C24D-4FB7-BD04-4CB2D0FD9BE2Q48016716-59443450-2778-4503-B8B6-358464AD2707Q52093966-2207D869-820A-48FA-B584-D2F1EE6FD4C0Q55711310-5EE47867-D25F-4583-A859-FD96FA14709CQ56352635-648C69B2-866E-40CF-BAE0-924052CC031F
P2860
Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Parasite clearance rates in Up ...... : a therapeutic efficacy study
@en
type
label
Parasite clearance rates in Up ...... : a therapeutic efficacy study
@en
prefLabel
Parasite clearance rates in Up ...... : a therapeutic efficacy study
@en
P2093
P2860
P50
P1433
P1476
Parasite clearance rates in Up ...... : a therapeutic efficacy study
@en
P2093
Atthanee Jeeyapant
Cholrawee Promnarate
Elizabeth A Ashley
Frank M Smithuis
Kyaw Myo Tun
Mehul Dhorda
Prayoon Yuentrakul
Sai Soe Moe Aung
Tin Maung Hlaing
P2860
P2888
P356
10.1186/S12936-016-1240-7
P577
2016-03-31T00:00:00Z
P5875
P6179
1029182490